SCHOENBERG MARK (Chief Medical Officer) sold 3.2% of their position (5.15K shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $98.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/30/2025ACC: 0001437749-25-023961
Officer· Chief Medical Officer
Since Jan 2019
+4.85K
Net shares
Net buyer
$98.6K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
10K acquired · 5.15K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+10K
Price / share
—
Trade value
—
% of position
6.5%
7/28/2025
153.38K→163.38K
Ordinary Shares
Direct
Shares
−5.15K
Price / share
$19.14
Trade value
$98.55K
% of position
3.2%
7/28/2025
163.38K→158.23K
Total
Net shares
+4.85K
Net value
-$98.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 7/28/2025 | M · Option Exercise | +10K | — | — | 6.5% | 153.38K | 163.38K |
| Ordinary Shares Direct | 7/28/2025 | S · Sale | −5.15K | $19.14 | $98.55K | 3.2% | 163.38K | 158.23K |
| Total | +4.85K | -$98.55K | ||||||
Derivative Transactions0
No derivative transactions reported